Would you consider Injectable ART for those unable to suppress with oral HIV treatment?

Would you consider Injectable ART for those unable to suppress with oral HIV treatment?

In this episode, Dr. Steven Fine discusses some of the latest data that might be used to support starting patients who are unable to take oral antiretroviral medications on long acting, injectable ARV. Patients who consider this off label use because their HIV viral load was not suppressed on oral treatment would have to be carefully selected and well supported. Related Content:

  • Long-acting Injectable Cabotegravir/Rilpivirine Effective in a Small Patient Cohort With Virologic Failure on Oral Antiretroviral Therapy. James B. Brock, Peyton Herrington, Melissa Hickman, and Aubri Hickman. Department of Medicine, Division of Infectious Diseases, University of Mississippi Medical Center. Jackson, Mississippi, USA. Clinical Infectious Diseases, Volume 78, Issue 1, 15 January 2024, Pages 122–124, https://doi.org/10.1093/cid/ciad511
  • CROI 2024: Abstract number 628 24 Week Viral Suppression in Patients Starting Long-Acting CAB/RPV Without HIV Viral Suppression. Matthew D Hickey, Janet Grochowski, Francis Mayorga-Munoz, Elizabeth Imbert, John D. Szumowski, Jon Oskarsson, Mary Shiels, Samantha Dilworth, Ayesha Appa, Diane V Havlir, Monica Gandhi, Katerina Christopoulos. Division of HIV, Infectious Disease, & Global Medicine, University of California, San Francisco, CA, United States.
  • CROI 2024: ABSTRACT NUMBER 212. SESSION TITLE. Special Session. Clinical Late-Breaking Oral Abstracts. SESSION NUMBER Oral Session-14. Long-Acting Injectable CAB/RPV is Superior to Oral ART in PWH With Adherence Challenges: ACTG A5359. Aadia I. Rana, Yajing Bao, Lu Zheng, Sara Sieczkarski, Jordan E. Lake, Carl J. Fichtenbaum, Tia Morton, Lawrence Fox, Paul Wannamaker, Jose R. Castillo-Mancilla, Kati Vandermeulen, Chanelle Wimbish, Karen T. Tashima, Raphael J. Landovitz
  • CEI toll free line for NYS providers: 866-637-2342
  • https://ceitraining.org/

Jaksot(58)

Where Are We Now With HIV and COVID-19

Where Are We Now With HIV and COVID-19

As we enter year three of the COVID-19 pandemic, we would like to review the latest updates about HIV and COVID-19. In the first segment we will speak with Dr. Robert Fullilove, EdD, about the social ...

14 Huhti 202250min

Behind the Scenes: A Look at the 2021 CDC STI Treatment Guidelines

Behind the Scenes: A Look at the 2021 CDC STI Treatment Guidelines

In July 2021, the Centers for Disease Control and Prevention released new evidence-based guidelines for the prevention, diagnosis, and treatment of sexually transmitted infections. This is the first n...

10 Maalis 202235min

One Step Closer: Introducing the New York State Hepatitis C Elimination Plan

One Step Closer: Introducing the New York State Hepatitis C Elimination Plan

Hepatitis C is a major public health issue responsible for more deaths in the US than all 60 reportable infectious diseases combined, including HIV and tuberculosis. It infects about 25,000 people eac...

10 Helmi 202225min

Simplified HCV Treatment for treatment naive patients: Anyone can do it!

Simplified HCV Treatment for treatment naive patients: Anyone can do it!

According to the updated HCV guidelines, initial treatment of HCV infection includes patients with chronic hepatitis C who have not been previously treated with interferon, peginterferon, ribavirin, o...

13 Tammi 202224min

Addressing the Intersections of HIV and Health Inequities: Considerations for Providers

Addressing the Intersections of HIV and Health Inequities: Considerations for Providers

It has been 40 years since the first known case of HIV was documented and we have come a long way in the past 40 years. HIV is now a chronic disease, we have highly effective HIV prevention options li...

9 Joulu 20211h 5min

The Intersection of Drug User Health and Infectious Diseases

The Intersection of Drug User Health and Infectious Diseases

Join us for the fifth and final episode of Any Positive Change, a Drug User Health Podcast. Dr. Margie Urban from the University of Rochester and the Clinical Education Initiative’s Sexual Health Cent...

7 Joulu 202146min

Pre-Exposure Prophylaxis (PrEP): What Clinicians Need to Know

Pre-Exposure Prophylaxis (PrEP): What Clinicians Need to Know

[The following episode was initially recorded as part of "Any Positive Change", which has since merged with Conversations with CEI] Pre-exposure prophylaxis, also known as PrEP, is a highly effective ...

28 Kesä 202156min

Updates in Sexually Transmitted Infections and Sexual Health

Updates in Sexually Transmitted Infections and Sexual Health

[The following episode was initially recorded as part of "Any Positive Change", which has since merged with Conversations with CEI] In this episode, Dr. Linda Wang interviews Dr. Margie Urban, an infe...

4 Kesä 202140min

Suosittua kategoriassa Koulutus

rss-murhan-anatomia
voi-hyvin-meditaatiot-2
psykopodiaa-podcast
adhd-podi
rss-narsisti
psykologia
kesken
rss-vapaudu-voimaasi
rahapuhetta
rss-niinku-asia-on
rss-liian-kuuma-peruna
rss-duodecim-lehti
rss-valo-minussa-2
rss-luonnollinen-synnytys-podcast
rss-tietoinen-yhteys-podcast-2
aamukahvilla
rss-uskonto-on-tylsaa
rss-honest-talk-with-laurrenna
nakokulmia-rikollisuudesta-irrottautumiseen
rss-ai-mita-siskopodcast